Systemic corticosteroid regimens for prevention of bronchopulmonary dysplasia in preterm infants. (Q30238696)

30 June 2019

meta-analysis

0 references

title

Systemic corticosteroid regimens for prevention of bronchopulmonary dysplasia in preterm infants. (English)

1 reference

30 June 2019

bronchopulmonary dysplasia

main subject

preterm infant

0 references

1 reference

3

1 reference

30 June 2019

author name string

Wes Onland

series ordinal

1

1 reference

30 June 2019

Anne Pmc De Jaegere

series ordinal

2

1 reference

30 June 2019

Anton van Kaam

series ordinal

4

1 reference

30 June 2019

publication date

31 January 2017

1 reference

30 June 2019

Cochrane Database of Systematic Reviews

published in

1 reference

30 June 2019

volume

1

1 reference

30 June 2019

page(s)

CD010941

1 reference

30 June 2019

Follow up of a randomised trial of two different courses of dexamethasone for preterm babies at risk of chronic lung disease

cites work

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD010941.PUB2

A controlled trial of dexamethasone in preterm infants at high risk for bronchopulmonary dysplasia.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD010941.PUB2

Follow-up at 15 years of preterm infants from a controlled trial of moderately early dexamethasone for the prevention of chronic lung disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD010941.PUB2

A randomized trial of moderately early low-dose dexamethasone therapy in very low birth weight infants: dynamic pulmonary mechanics, oxygenation, and ventilation

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD010941.PUB2

A multicenter, randomized open study of early corticosteroid treatment (OSECT) in preterm infants with respiratory illness: comparison of early and late treatment and of dexamethasone and inhaled budesonide

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD010941.PUB2

Randomized, double-blinded trial of low-dose dexamethasone: II. Functional residual capacity and pulmonary outcome in very low birth weight infants at risk for bronchopulmonary dysplasia.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD010941.PUB2

Early versus late dexamethasone treatment in preterm infants at risk for chronic lung disease: a randomized pilot study.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD010941.PUB2

High incidence of nephrocalcinosis in extremely preterm infants treated with dexamethasone

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD010941.PUB2

A randomized trial of two dexamethasone regimens to reduce side-effects in infants treated for chronic lung disease of prematurity

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD010941.PUB2

Dexamethasone therapy increases infection in very low birth weight infants

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD010941.PUB2

Early neonatal dexamethasone treatment for prevention of bronchopulmonary dysplasia. Randomised trial and meta-analysis evaluating the duration of dexamethasone therapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD010941.PUB2

Aerobic Fitness and Physical Activity Levels of Children Born Prematurely following Randomization to Postnatal Dexamethasone

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD010941.PUB2

Postnatal corticosteroids to treat or prevent chronic lung disease in preterm infants

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD010941.PUB2

Definitions and diagnostic criteria for bronchopulmonary dysplasia

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD010941.PUB2

Effect of pulse dexamethasone therapy on the incidence and severity of chronic lung disease in the very low birth weight infant

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD010941.PUB2

Postnatal corticosteroids and neurodevelopmental outcomes in extremely low birthweight or extremely preterm infants: 15-year experience in Victoria, Australia

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD010941.PUB2

Pathology of bronchopulmonary dysplasia

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD010941.PUB2

Postnatal hydrocortisone for preventing or treating bronchopulmonary dysplasia in preterm infants: a systematic review

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD010941.PUB2

An update on the impact of postnatal systemic corticosteroids on mortality and cerebral palsy in preterm infants: effect modification by risk of bronchopulmonary dysplasia

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD010941.PUB2

Early (< 8 days) postnatal corticosteroids for preventing chronic lung disease in preterm infants

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD010941.PUB2

Late (> 7 days) postnatal corticosteroids for chronic lung disease in preterm infants

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD010941.PUB2

Validation of the National Institutes of Health consensus definition of bronchopulmonary dysplasia

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD010941.PUB2

Circulating neutrophil concentration and respiratory distress in premature infants

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD010941.PUB2

Early postnatal (<96 hours) corticosteroids for preventing chronic lung disease in preterm infants

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD010941.PUB2

Moderately early (7-14 days) postnatal corticosteroids for preventing chronic lung disease in preterm infants

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD010941.PUB2

Late (>7 days) postnatal corticosteroids for chronic lung disease in preterm infants

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD010941.PUB2

Estimating the mean and variance from the median, range, and the size of a sample

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD010941.PUB2

Effects of neonatal corticosteroid treatment on hippocampal synaptic function

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD010941.PUB2

Bronchopulmonary dysplasia

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD010941.PUB2

Differences in behavioral outcome and motor development at school age after neonatal treatment for chronic lung disease with dexamethasone versus hydrocortisone

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD010941.PUB2

Children of birth weight less than 1000 g: changing outcome between ages 2 and 5 years

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD010941.PUB2

Structural and functional brain development after hydrocortisone treatment for neonatal chronic lung disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD010941.PUB2

Pulmonary disease following respirator therapy of hyaline-membrane disease. Bronchopulmonary dysplasia

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD010941.PUB2

Randomized placebo-controlled trial of a 42-day tapering course of dexamethasone to reduce the duration of ventilator dependency in very low birth weight infants: outcome of study participants at 1-year adjusted age.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD010941.PUB2

Finding the optimal postnatal dexamethasone regimen for preterm infants at risk of bronchopulmonary dysplasia: a systematic review of placebo-controlled trials.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD010941.PUB2

Open-label glucocorticoids modulate dexamethasone trial results in preterm infants.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD010941.PUB2

Neonatal hydrocortisone treatment: neurodevelopmental outcome and MRI at school age in preterm-born children

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD010941.PUB2

Evidence-based neonatal drug therapy for prevention of bronchopulmonary dysplasia in very-low-birth-weight infants

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD010941.PUB2

Neonatologists are using much less dexamethasone

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD010941.PUB2

Less postnatal steroids, more bronchopulmonary dysplasia: a population-based study in very low birthweight infants

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD010941.PUB2

Developmental sequelae in preterm infants having a diagnosis of bronchopulmonary dysplasia: analysis using a severity-based classification system

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD010941.PUB2

Neonatal outcomes of extremely preterm infants from the NICHD Neonatal Research Network

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD010941.PUB2

Extremely low birthweight neonates with protracted ventilation: mortality and 18-month neurodevelopmental outcomes

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD010941.PUB2

Changes in the use of postnatal steroids for bronchopulmonary dysplasia in 3 large neonatal networks

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD010941.PUB2

Growth and neurodevelopmental outcomes after early low-dose hydrocortisone treatment in extremely low birth weight infants

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD010941.PUB2

Policy statement--postnatal corticosteroids to prevent or treat bronchopulmonary dysplasia

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD010941.PUB2

Early dexamethasone therapy in preterm infants: a follow-up study

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD010941.PUB2

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD010941.PUB2

Effects of higher versus lower dexamethasone doses on pulmonary and neurodevelopmental sequelae in preterm infants at risk for chronic lung disease: a meta-analysis

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD010941.PUB2

Side effects of 2 different dexamethasone courses for preterm infants at risk of chronic lung disease: A randomized trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD010941.PUB2

Impact of Postnatal Systemic Corticosteroids on Mortality and Cerebral Palsy in Preterm Infants: Effect Modification by Risk for Chronic Lung Disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD010941.PUB2

The new BPD: an arrest of lung development

21 January 2018

1 reference

12 December 2020

Implementing potentially better practices to improve neonatal outcomes after reducing postnatal dexamethasone use in infants born between 501 and 1250 grams.

1 reference

12 December 2020

Short- and long-term effects of neonatal glucocorticoid therapy: is hydrocortisone an alternative to dexamethasone?

1 reference

12 December 2020

Neurodevelopmental and Respiratory Follow-up Results at 7 Years for Children From the United Kingdom and Ireland Enrolled in a Randomized Trial of Early and Late Postnatal Corticosteroid Treatment, Systemic and Inhaled (the Open Study of Early Cortic

1 reference

12 December 2020

Dexamethasone therapy in neonatal chronic lung disease: an international placebo-controlled trial. Collaborative Dexamethasone Trial Group

1 reference

12 December 2020

Short term outcomes after extreme preterm birth in England: comparison of two birth cohorts in 1995 and 2006 (the EPICure studies).

1 reference

12 December 2020

Randomized Trial of 42-Day Compared with 9-Day Courses of Dexamethasone for the Treatment of Evolving Bronchopulmonary Dysplasia in Extremely Preterm Infants

1 reference

12 December 2020

Bronchopulmonary dysplasia. Unresolved neonatal acute lung injury

1 reference

12 December 2020

Effects of early dexamethasone therapy on pulmonary mechanics and chronic lung disease in very low birth weight infants: a randomized, controlled trial.

1 reference

12 December 2020

Levels of complement anaphylatoxin C5a in pulmonary effluent fluid of infants at risk for chronic lung disease and effects of dexamethasone treatment

1 reference

12 December 2020

Effects of dexamethasone on chemotactic activity and inflammatory mediators in tracheobronchial aspirates of preterm infants at risk for chronic lung disease

1 reference

12 December 2020

Early Postnatal Dexamethasone Therapy for the Prevention of Chronic Lung Disease in Preterm Infants With Respiratory Distress Syndrome: A Multicenter Clinical Trial

1 reference

12 December 2020

Role of neutrophils in lung vascular injury and edema after premature birth in lambs

1 reference

12 December 2020

A Multicenter Trial of Two Dexamethasone Regimens in Ventilator-Dependent Premature Infants

1 reference

12 December 2020

Pathology of arrested acinar development in postsurfactant bronchopulmonary dysplasia

1 reference

12 December 2020

10.1002/14651858.CD010941.PUB2

Identifiers

DOI

1 reference

30 June 2019

PMC publication ID

6464844

1 reference

30 June 2019

PubMed publication ID

28141913

1 reference

30 June 2019